Last update 21 Mar 2026

Toko Pharmaceutical Industrial Co. Ltd.

Private Company|Japan|
www.medicine.co.jp

Overview

Tags

Skin and Musculoskeletal Diseases
Other Diseases
Immune System Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases2
Hemic and Lymphatic Diseases2
Neoplasms2
Immune System Diseases2
Infectious Diseases1
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Small molecule drug4
Top 5 TargetCount
GR(Glucocorticoid receptor)1
COXs(Cyclooxygenases)1
RARα(Retinoic acid receptor alpha)1

Related

4
Drugs associated with Toko Pharmaceutical Industrial Co. Ltd.
Tamibarotene
Target
RARα
Mechanism
RARα agonists
Active Org.
Toko Pharmaceutical Industrial Co. Ltd. [+3]
Originator Org.
Nippon Shinyaku Co., Ltd.Nippon Shinyaku Co., Ltd.
Active Indication
Acute Promyelocytic Leukemia [+2]
Inactive Indication
Advanced Hepatocellular Carcinoma [+10]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
Japan
First Approval Date11 Apr 2005
Methyl Salicylate/l-Menthol /dl-Camphor
Target-
Mechanism-
Active Org.
Toko Pharmaceutical Industrial Co. Ltd. [+1]
Originator Org.
Taiho Pharmaceutical Co., Ltd.Taiho Pharmaceutical Co., Ltd.
Active Indication
Inflammation [+1]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
Japan
First Approval Date01 Jul 1996
Dexamethasone Propionate
Target
GR
Mechanism
GR agonists
Active Org.
Toko Pharmaceutical Industrial Co. Ltd.
Originator Org.
Toko Pharmaceutical Industrial Co. Ltd.
Active Indication
Eczema [+6]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
Japan
First Approval Date12 Jan 1987
1
Clinical Trials associated with Toko Pharmaceutical Industrial Co. Ltd.
CTR20130280
/ Recruiting
他米巴罗汀片（OMS0728）治疗复发或难治性急性早幼粒细胞白血病（APL）的有效性、安全性验证试验
[Translation] Efficacy and safety validation trial of Tamibarotene tablets (OMS0728) in the treatment of relapsed or refractory acute promyelocytic leukemia (APL)
100 Clinical Results associated with Toko Pharmaceutical Industrial Co. Ltd.
Login to view more data
0 Patents (Medical) associated with Toko Pharmaceutical Industrial Co. Ltd.
Login to view more data
100 Deals associated with Toko Pharmaceutical Industrial Co. Ltd.
Login to view more data
100 Translational Medicine associated with Toko Pharmaceutical Industrial Co. Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 24 Mar 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
4
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Dexamethasone Propionate
 ( GR )		Eczema
More
Approved
Indomethacin
 ( COXs )		Pain
More
Approved
Tamibarotene
 ( RARα )		Acute Promyelocytic Leukemia
More
Approved
Methyl Salicylate/l-Menthol /dl-Camphor
Pain
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free